default author photo

Mathieu Surenaud

Université Paris Est Créteil

SCHOLARLY PAPERS

3

DOWNLOADS

348

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Symptoms and Pathophysiology of Post-Acute Sequelae of SARS-CoV-2 (PASC): A Cohort Study

Number of pages: 29 Posted: 09 Dec 2024
Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Université Paris Est Créteil, Université Paris Est Créteil, University of Paris - Institute of Psychiatry and Neuroscience of Paris (IPNP), Sorbonne-Université, Université Paris Saclay, Université Paris Est Créteil, Sorbonne-Université, Aix Marseille Université - Emerging Viruses Unit, Fondation Jean Dausset-CEPH (Centre d’Etude du Polymorphisme Humain), Fondation Jean Dausset-CEPH (Centre d’Etude du Polymorphisme Humain), Université Paris Saclay, Université Paris Saclay, University of Paris-Saclay - Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Sorbonne Paris Nord University - Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Université de Versailles Saint-Quentin, Université Paris Est Créteil, Université Paris Est Créteil and Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP
Downloads 163 (461,984)

Abstract:

Loading...

SARS-CoV-2, PASC, long COVID, biomarkers, post-infectious symptoms

2.

Antibody-Mediated Targeting of SOSIP HIV-1 Env to Skin Langerhans Cells Potentiates Humoral Responses

Number of pages: 36 Posted: 11 Aug 2025
Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil, University of Bonn - Institute of Structural Biology, University of Bonn - Institute of Structural Biology, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University Grenoble Alpes - Institute of Structural Biology (IBS), Université Paris Est Créteil, Université Paris Est Créteil, Université Paris Est Créteil and University of Nantes - INSERM
Downloads 112 (635,507)

Abstract:

Loading...

Antibody-mediated vaccine, DC-targeting, Skin Langerhans cells, HIV-1 Env BG505 SOSIP, Neutralizing Ab

3.

Non-adjuvanted CD40-targeting SARS-CoV-2 Vaccines Induce Broad Long-lasting Protection in Non-human Primates

Number of pages: 48 Posted: 19 Sep 2025
University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris Est Créteil, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Bordeaux - ISPED, INSERM U1219, Inria BSO, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris Est Créteil, University of Lausanne - Service of Immunology and Allergy, University of Nantes - INSERM, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Lausanne - Service of Immunology and Allergy, University of Bordeaux - SISTM team, UMR 1219, University of Bordeaux - SISTM team, UMR 1219, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Claude Bernard Lyon 1 - Inserm
Downloads 73 (867,774)

Abstract:

Loading...

Preclinical study, Immunogenicity, SARS-CoV-2 vaccine candidate, Non-Human Primate, dendritic cell targeting vaccine, CD40